Merck 3Q Keytruda Sales Rise 6%
Story updates
10:39:47 AM UTC
SquawkNews
Merck 3Q Keytruda Sales $8.6B >MRK
Related stories
AstraZeneca Reports 7% Nine-Month Revenue Growth, Reiterates FY26 Guidance
Revenue for the nine months ended September 30 rose 7% to $46.88 billion. Reported EPS increased 10% to $5.62, while operating profit rose 10% to $11.80 billion and underlying earn
M impact | EARNINGS | Oct 30, 2026, 09:58 AM UTC
SCOR’s Third-Quarter Net Profit Falls Less Than Expected
M impact | EARNINGS | Oct 30, 2026, 09:45 AM UTC
Sun Pharma Profit Falls on Costs Tied to Organon Deal
Sun Pharma said profit fell due to expenses related to its Organon transaction, while specialty drug sales remained solid.
M impact | EARNINGS | Oct 30, 2026, 09:19 AM UTC
Magna Beats Q3 Adjusted EPS Estimates, Raises FY Free-Cash-Flow Forecast
Magna reported Q3 adjusted EPS above estimates and raised its full-year free-cash-flow forecast.
M impact | EARNINGS | Oct 30, 2026, 09:13 AM UTC
Volkswagen Core Brand Group Reports Nine-Month Revenue of EUR106.42B
M impact | EARNINGS | Oct 30, 2026, 09:04 AM UTC
Coinbase Q3 Net Income Jumps 66% to $719 Million
Coinbase reported third-quarter net income of $719 million. Its prediction markets and derivatives businesses helped offset weaker spot trading activity, analysts said.
M impact | EARNINGS | Oct 30, 2026, 09:01 AM UTC